Zota Health Care Ltd. (IN:ZOTA)
:ZOTA
ZOTA Stock Chart & Stats
₹1533.20
₹23.30(2.41%)
At close: 4:00 PM EST
₹1533.20
₹23.30(2.41%)
Day’s Range― - ―
52-Week Range₹760.00 - ₹1,740.00
Previous CloseN/A
Volume255.13K
Average Volume (3M)68.23K
Market Cap
₹37.12B
Enterprise Value₹39.20B
Total Cash (Recent Filing)₹63.18M
Total Debt (Recent Filing)₹1.81B
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Jun 03, 2026EPS Estimate
-18.4Next Dividend Ex-DateN/A
Dividend Yield0.06%
Share Statistics
EPS (TTM)-8.90
Shares Outstanding30,332,655
10 Day Avg. Volume83,032
30 Day Avg. Volume68,228
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)10.00
Price to Sales (P/S)7.63
P/FCF Ratio-23.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-15
Revenue Forecast (FY)₹11.03B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained high revenue growth expands market presence and provides scale benefits: it can fund capacity, R&D and distribution investments over months. If maintained, top-line momentum underpins the company’s ability to pursue market share and long-term product commercialization.
Healthy Gross MarginsA 53% gross margin indicates structural pricing power or efficient manufacturing of formulations. High gross margins create a durable buffer to absorb SG&A and R&D spend, improving the potential to generate operating leverage as sales scale and cost controls tighten.
Balanced Capital StructureModerate leverage with an equity ratio near 51% suggests a balanced capital structure that can support expansion without extreme debt burden. This provides flexibility to finance growth initiatives or absorb shocks if operating performance improves and cash generation recovers.
Bears Say
Negative ProfitabilityPersistently negative margins imply core profitability issues: costs and operating inefficiencies are outpacing revenue gains. Over the medium term, continued losses impair retained earnings, limit reinvestment capacity, and raise the bar for management to convert sales growth into sustainable profits.
Weak Cash GenerationNegative operating and free cash flow mean the business depends on external financing to fund operations and capex. This constraint limits strategic flexibility, risks dilution or higher leverage, and makes it harder to sustain investments needed to convert revenue growth into lasting profitability.
Negative Return On EquityA negative ROE signals the company is destroying shareholder capital rather than creating it. Over several quarters this undermines investor confidence and indicates operational challenges: converting strong revenue growth into acceptable returns will require material margin and cash-flow improvement.
Zota Health Care Ltd. News
ZOTA FAQ
What was Zota Health Care Ltd.’s price range in the past 12 months?
Zota Health Care Ltd. lowest stock price was ₹760.00 and its highest was ₹1740.00 in the past 12 months.
What is Zota Health Care Ltd.’s market cap?
Zota Health Care Ltd.’s market cap is ₹37.12B.
When is Zota Health Care Ltd.’s upcoming earnings report date?
Zota Health Care Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 54 days.
How were Zota Health Care Ltd.’s earnings last quarter?
Zota Health Care Ltd. released its earnings results on Feb 04, 2026. The company reported -₹8.9 earnings per share for the quarter, missing the consensus estimate of N/A by -₹8.9.
Is Zota Health Care Ltd. overvalued?
According to Wall Street analysts Zota Health Care Ltd.’s price is currently Overvalued.
Does Zota Health Care Ltd. pay dividends?
Zota Health Care Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.06%. See more information on Zota Health Care Ltd. dividends here
What is Zota Health Care Ltd.’s EPS estimate?
Zota Health Care Ltd.’s EPS estimate is -18.4.
How many shares outstanding does Zota Health Care Ltd. have?
Zota Health Care Ltd. has 30,332,655 shares outstanding.
What happened to Zota Health Care Ltd.’s price movement after its last earnings report?
Zota Health Care Ltd. reported an EPS of -₹8.9 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.874%.
Which hedge fund is a major shareholder of Zota Health Care Ltd.?
Currently, no hedge funds are holding shares in IN:ZOTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zota Health Care Ltd.
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.
Technical Analysis
Alembic Limited
―
Indoco Remedies Limited
―
Panacea Biotec Limited
―
SMS Pharmaceuticals Limited
―
Solara Active Pharma Sciences Ltd.
―